SynthesisFrontiers in oncology2025

Meta-analysis on the safety and efficacy of Erdafitinib in treating FGFR1-4 mutated solid tumors.

Jiyu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.